MRNA - Moderna, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 54.62B
Enterprise Value 33.57B
Trailing P/E N/A
Forward P/E 1-7.76
PEG Ratio (5 yr expected) 1-0.78
Price/Sales (ttm)37.87
Price/Book (mrq)3.20
Enterprise Value/Revenue 329.22
Enterprise Value/EBITDA 6-7.91

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 3∞%
S&P500 52-Week Change 35.54%
52 Week High 329.79
52 Week Low 313.03
50-Day Moving Average 315.31
200-Day Moving Average 319.50

Share Statistics

Avg Vol (3 month) 31.29M
Avg Vol (10 day) 3983.2k
Shares Outstanding 5329M
Float 170.83M
% Held by Insiders 126.31%
% Held by Institutions 140.84%
Shares Short (Jun 28, 2019) 49.51M
Short Ratio (Jun 28, 2019) 44.79
Short % of Float (Jun 28, 2019) 44.15%
Short % of Shares Outstanding (Jun 28, 2019) 42.89%
Shares Short (prior month May 31, 2019) 410.74M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin 0.00%
Operating Margin (ttm)-391.38%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)-42.97%

Income Statement

Revenue (ttm)122.05M
Revenue Per Share (ttm)0.83
Quarterly Revenue Growth (yoy)-44.80%
Gross Profit (ttm)-319.01M
EBITDA -450.66M
Net Income Avi to Common (ttm)-458.66M
Diluted EPS (ttm)-3.12
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.11B
Total Cash Per Share (mrq)3.37
Total Debt (mrq)33.38M
Total Debt/Equity (mrq)2.31
Current Ratio (mrq)7.17
Book Value Per Share (mrq)4.40

Cash Flow Statement

Operating Cash Flow (ttm)-363.41M
Levered Free Cash Flow (ttm)N/A